FDA CONTINUES ITS TWIST PMTA REVIEW!
FOR IMMEDIATE RELEASE
October 22, 2021
Fumizer LLC, the manufacturer of Twist E-Liquids vapor products, recently received notice that the Food and Drug Administration (FDA) rescinded its September 9, 2021 Marketing Denial Order for certain flavored vapor products with pending Premarket Tobacco Product Applications (PMTA). The rescission noted that upon further review the FDA found relevant information that was not adequately assessed previously. Therefore, Twist E-liquids’ products have been placed back into the review process, and will continue to be marketed while they remain under review.
Twist E-liquids continues to support this multi-year process, since it is important that quality e-liquids remain available for consumers while restricting access to minors. This exciting next step in the PMTA review process allows Twist E-liquids to continue producing and distributing its line of freebase and salt flavors to distributors and retailers domestically and worldwide.
Fumizer thanks all customers and business affiliates for your continued support and patience. We understand that the PMTA process will be long but we look forward to a bright future ahead.
Please remember to visit www.Fumizer.com for updates, original content, and links to collateral that will be available to our partners.
Director of Marketing and Public Relations